molecular cancer

  • Molecular subtypes of pancreatic cancer

    Feb 04 2019  In contrast to other cancers such as breast and colon cancers molecular subtyping of pancreatic cancer is in its infancy and remains without clinically relevant morphological or molecular

  • Molecular Cellular Oncology

    The Department of Molecular and Cellular Oncology MCO mission is to enable and apply basic research excellence to contribute to ending cancer significantly The department s oncology driven research focuses on fundamental mechanistic discoveries and their translation to humans As a basic science department at The University of Texas MD

  • MBCF at DFCI Molecular Biology Core Facilities at Dana

    The Molecular Biology Core Facilities MBCF at Dana Farber Cancer institute DFCI provide expertise and access to cutting edge genomic and proteomic technologies in a shared use setting Although these services are primarily focused on cancer and AIDS research most services are broadly applicable to other areas of research

  • Amazon Molecular Biology of Cancer Mechanisms

    Molecular Biology of Cancer Mechanisms Targets and Therapeutics offers an accessible engaging and optimistic account of cancer biology for undergraduate and graduate students Drawing on the latest research in this dynamic field

  • Molecular Oncology

    Program Information Molecular Oncology is an integrated basic science program composed of a diverse group of investigators with strengths in cancer stem cells DNA damage repair and genomic instability tumor host interactions and other fundamental areas of cancer biology

  • Molecular Imaging Branch

    The goal of the Molecular Imaging Branch MIB is to develop targeted imaging methods that accelerate the development of cancer therapies The MIB is focused on the development and translation of in vivo molecular imaging agents for early detection monitoring and therapy Given the high risks and high costs of conducting research in this field the MIB is well positioned to

  • Molecular Cancer Biology

    The molecular cancer biologists at Duke University seek to understand the complex regulatory mechanisms that govern mammalian cell growth and differentiation discern how these mechanisms are perturbed in malignant cells and how our knowledge of these regulatory mechanisms might lead to improved anti cancer therapy This research covers the boundaries

  • The Molecular Basis of Cancer Cell Behavior

    The uncertainties highlight how little we still know about the natural history of cancer despite the dramatic advances in understanding of cancer molecular genetics At the very least however the results suggest that telomere deficient mice can provide a reasonable model for the study of common human carcinomas

  • Program

    Please Note All session times for the AACR NCI EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics are U S Eastern Time ET short talk from highly rated proffered paper Thursday October 7 Poster Sessions9 a m on demand throughout conference Educational Sessions10 11 20 A M EDUCATIONAL SESSION 1 Exploiting

  • NCI Dictionary of Cancer Terms

    NCI s Dictionary of Cancer Terms provides easy to understand definitions for words and phrases related to cancer and medicine

  • The Consensus Molecular Subtypes of Colorectal Cancer

    Perez Villamil B et al Colon cancer molecular subtypes identified by expression profiling and associated to stroma mucinous type and different clinical behavior BMC Cancer 2012 12 260 PMC free article Google Scholar

  • Molecular classification of gastric cancer

    Areas covered Recent comprehensive molecular profiling of gastric cancer proposed four molecular subtypes i e Epstein Barr virus associated microsatellite instable chromosomal instable and genomically stable carcinomas The new molecular classification will spur clinical trials exploring novel targeted therapeutics

  • The Molecular Basis of Cancer

    May 01 1996  Molecular oncology as it relates to cancer formation growth metastasis and treatment is a rapidly progressing and exciting field Its forward movement is so fast that even scientific journals because of publication delays are unable to keep readers informed in

  • About Molecular Cancer Research

    Scope Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field Studies must be of demonstrated significance and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk development and/or

  • Molecular Mechanisms of Cancer

    The Molecular Mechanisms of Cancer Program focuses on determining the basic cell signaling and gene expression mechanisms that underlie malignancy The program brings together basic and translational investigators from 13 departments with a wealth of experience in cancer biology chemistry cell signaling systems biology developmental biology

  • About Molecular Cancer Therapeutics

    Scope Molecular Cancer Therapeutics publishes translational research studies focused on the discovery and preclinical development of therapeutic agents for oncology To reflect the evolving field of therapeutics the journal s interest extends to all selective drugs including small molecule inhibitors antibody drug conjugates antibody cytokine fusions bispecific antibodies cell

  • Molecular Cancer

    Molecular Cancer promotes the exchange of ideas concepts and findings in any area of cancer and related biomedical science from a molecular point of view Molecular Cancer is interested in articles from basic translational and clinical research opening new avenues for the understanding prevention diagnosis and treatment of cancer

  • Cellular and Molecular Basis of Cancer

    A cancer may release cells into the circulation at a very early stage of development From animal models it is estimated that a 1 cm tumor sheds > 1 million cells/24 hours into the venous circulation Circulating cancer cells are present in many patients with advanced cancer and even in some with localized disease

  • The Current Molecular Treatment Landscape of Advanced

    Sep 15 2021  The ACCRU consortium developed a screening umbrella platform for this purpose entitled COlorectal Cancer and Liquid BiOpsy Screening Protocol for Molecularly Assigned ThErapy or COLOMATE NCT 57 This platform utilizes molecular profiling through the Guardant360 liquid NGS panel to identify potential patients for the COLOMATE

  • Abbott Molecular

    UROVYSION BLADDER CANCER KIT The only urine based molecular test approved by the FDA to aid in bladder cancer surveillance and assist with diagnosis VIEW PRODUCT DETAILS Explore Infectious Disease Instrumentation Oncology Solutions Support Making an everlasting impact on human health for 125 years

  • OnlineFirst

    Molecular Cancer Research publishes two types of OnlineFirst articles OnlineFirst Author Manuscripts are PDF versions of manuscripts that have been peer reviewed and accepted for publication but not yet copyedited or typeset allowing readers the most rapid access to accepted papers They appear on the OnlineFirst page as submitted by the

  • Molecular Pathology

    The Molecular Pathology Shared Resource MPSR facilitates tissue based human and experimental basic science and translational cancer research through three integrated services Histology Tumor banking and Macromolecule platform next generation banking

  • Types of Molecular Tumor Testing

    Often cancer causing mutations cluster in hotspots where tumors from different patients harbor the same recurrent mutation Some hotspot SNVs may occur frequently while others are rare For example the BRAF V600E mutation occurs in 40 of all melanomas while the BRAF L597S mutation occurs in <1 of all melanomas Tests for molecular profiling of tumors range from

  • Molecular Cancer Latest Impact Factor IF 2020 2021

    Nov 23 2021  Molecular Cancer promotes the exchange of ideas concepts and findings in any area of cancer and related biomedical science from a molecular point of view Molecular Cancer is interested in articles from basic translational and clinical research opening new avenues for the understanding prevention diagnosis and treatment of cancer

  • Tumor Markers

    NCI s Molecular Applications for Therapy Choice and NCI COG Pediatric MATCH clinical trials are using a precision medicine approach to assign patients to treatment by gene mutations in their tumors rather than by the type of cancer they have By analyzing the response of patients to these targeted agents and the underlying genomic

  • Molecular mechanisms of cancer

    Molecular mechanisms of cancer West J Med 1991 Nov155 5 505 14 Authors H P Koeffler 1 F McCormick C Denny Affiliation 1 Department of Medicine Cedars Sinai Medical Center UCLA School of Medicine 90048 PMID PMCID PMC Abstract

  • Molecular Cell and Cancer Biology MCCB

    The Molecular Cell and Cancer Biology MCCB center at UMass Medical School Worcester provides outstanding research contributions in all the fundamental mechanisms that lead to the onset progression and dissemination of cancer

  • The consensus molecular subtypes of colorectal cancer

    Oct 12 2015  An international consortium of colorectal cancer researchers undertakes a large scale data sharing project to achieve a consensus molecular classification of colorectal cancers Colorectal cancer

  • Molecular Oncology Testing for Cancer Diagnosis Prognosis

    Thyroid Cancer Molecular profiling of thyroid nodules e g Afirma GSC ThyroSeq V3 ThyGeNEXT/ThyraMIR or the gene and gene fusion panel BRAF RAS HRAS NRAS RET/PTC1 RET/PTC3 PAX8/PPARγ is proven and medically necessary when all of the following criteria are met Follicular pathool gy on fine needle aspiration is indeterminate

  • Molecular Cancer

    As an internationally recognized journal Molecular Cancer is dedicated to the innovation of how basic cancer research drives advances in cancer prevention

  • Molecular Cancer Therapeutics

    Mar 19 2004  Molecular Cancer Therapeutics covers state of the art strategies to identify and develop cancer drug target molecules and lead inhibitors for clinical testing It provides a thorough treatment of drug target discovery validation and development The introductory chapters provide an overview of pathways to discovery and development of molecular cancer

  • Molecular Biomarkers for the Evaluation of Colorectal

    Feb 06 2017  Purpose Molecular testing of colorectal cancers CRCs to improve patient care and outcomes of targeted and conventional therapies has been the center of many recent studies including clinical trials Evidence based recommendations for the molecular testing of CRC tissues to guide epidermal growth factor receptor EGFR –targeted therapies and

  • Early Detection of Molecular Residual

    Identifying molecular residual disease MRD after treatment of localized lung cancer could facilitate early intervention and personalization of adjuvant therapies Here we apply cancer personalized profiling by deep sequencing CAPP seq circulating tumor DNA ctDNA analysis to 255 samples from 40 patients treated with curative intent for stage I–III lung cancer and 54

  • Urinary Molecular Pathology for Patients with Newly

    Urine based molecular pathology provides a valid and complete genetic profile of bladder cancer and represents a faithful surrogate for genotyping and monitoring newly diagnosed UBC J Urol 2021 Oct206 4 873 884 doi 10 1097/JU

  • Molecular Oncology Program

    The Molecular Oncology Program brings together basic cancer biologists and physician scientists to discover and test novel compounds and treatment strategies for cancer The overarching goal of the Molecular Oncology Program is to discover and validate therapeutic targets and subsequently identify develop and test novel therapeutic strategies

  • Molecular Subtypes of Breast Cancer

    Nov 15 2021  The complex profile of each subtype is determined using molecular and genetic information from tumor cells Most studies divide breast cancer into 4 main molecular subtypes Luminal A Luminal B Triple negative/basal like HER2 enriched These subtypes also appear in ductal carcinoma in situ DCIS 46